Journal article
The Thrombogenic Effect of Anticancer Drug Therapy in Women with Stage II Breast Cancer
Abstract
Thromboembolic disease has long been recognized as a complication of cancer. Recent reports have suggested that drugs used in the treatment of cancer, including chemotherapeutic agents and hormones, may contribute to this risk, but it has not been possible to separate the effect of these drugs from that of the cancer. We performed a randomized trial comparing 12 weeks of chemohormonal therapy (using cyclophosphamide, methotrexate, fluorouracil, …
Authors
Levine MN; Gent M; Hirsh J; Arnold A; Goodyear MD; Hryniuk W; De Pauw S
Journal
The New England Journal of Medicine, Vol. 318, No. 7, pp. 404–407
Publisher
Massachusetts Medical Society
Publication Date
February 18, 1988
DOI
10.1056/nejm198802183180703
ISSN
0028-4793